BIORA THERAPEUTICS, INC.
Total Trades
2
Buys
1
Sells
1
Largest Trade
N/A
Insiders
2
Institutional Funds
1
Inst. Value
$500K+
Activist Filings
16
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Athyrium Opportunities III Co-Invest 1 LP | 10% Owner | BUY | N/A | 12.5M | — | Nov 14, 2022 |
| Sarna Surbhi | Director | SELL | $1K–$15K | 8K | $0.61 | Jul 5, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2023 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 279K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Athyrium Opportunities III Co-Invest 1 LP
SC 13D/A · Mar 27, 2025
36.5%
2.5M shares
Athyrium Opportunities III Co-Invest 1 LP 2
SC 13D/A · Oct 9, 2024
36.0%
1.9B shares
Athyrium Opportunities III Co-Invest 1 LP 2
SC 13D/A · Sep 13, 2024
36.0%
1.8B shares
SC 13G · Aug 20, 2024
2.8%
1.1M shares
Athyrium Opportunities III Co-Invest 1 LP 2
SC 13D/A · Aug 15, 2024
36.0%
1.8B shares
Athyrium Opportunities III Co-Invest 1 LP 2
SC 13D/A · Jul 9, 2024
35.9%
1.8B shares
Athyrium Opportunities III Co-Invest 1 LP 2
SC 13D/A · Apr 3, 2024
35.4%
1.4B shares
Context Capital Management, LLC
SC 13G · Mar 20, 2024
9.9%
3.0M shares
SC 13G/A · Feb 14, 2024
3.8%
1.1M shares
Athyrium Opportunities III Co-Invest 1 LP
SC 13D/A · Dec 20, 2023
34.9%
11.4M shares
Athyrium Opportunities III Co-Invest 1 LP
SC 13D/A · Sep 19, 2023
34.0%
8.4M shares
Athyrium Opportunities III Co-Invest 1 LP
SC 13D/A · Mar 13, 2023
16.4%
1.8M shares
SC 13G · Feb 14, 2023
5.7%
13.0M shares
Athyrium Opportunities III Co-Invest 1 LP
SC 13D/A · Jan 12, 2023
14.2%
1.5M shares
Athyrium Opportunities III Co-Invest 1 LP
SC 13D/A · Nov 18, 2022
14.6%
36.4M shares
SC 13G/A · Feb 14, 2022
2.2%
3.8M shares